We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Molina Healthcare (MOH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of MOH and the rest of the Medical group's stocks.
Molina Healthcare is a member of our Medical group, which includes 841 different companies and currently sits at #2 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. MOH is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for MOH's full-year earnings has moved 21.70% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Our latest available data shows that MOH has returned about 71.78% since the start of the calendar year. In comparison, Medical companies have returned an average of -0.30%. As we can see, Molina Healthcare is performing better than its sector in the calendar year.
Breaking things down more, MOH is a member of the Medical - HMOs industry, which includes 12 individual companies and currently sits at #87 in the Zacks Industry Rank. Stocks in this group have gained about 20.83% so far this year, so MOH is performing better this group in terms of year-to-date returns.
Going forward, investors interested in Medical stocks should continue to pay close attention to MOH as it looks to continue its solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Molina Healthcare (MOH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of MOH and the rest of the Medical group's stocks.
Molina Healthcare is a member of our Medical group, which includes 841 different companies and currently sits at #2 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. MOH is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for MOH's full-year earnings has moved 21.70% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Our latest available data shows that MOH has returned about 71.78% since the start of the calendar year. In comparison, Medical companies have returned an average of -0.30%. As we can see, Molina Healthcare is performing better than its sector in the calendar year.
Breaking things down more, MOH is a member of the Medical - HMOs industry, which includes 12 individual companies and currently sits at #87 in the Zacks Industry Rank. Stocks in this group have gained about 20.83% so far this year, so MOH is performing better this group in terms of year-to-date returns.
Going forward, investors interested in Medical stocks should continue to pay close attention to MOH as it looks to continue its solid performance.